Kawao Naoyuki, Nagataki Mami, Nagasawa Keita, Kubo Satoko, Cushing Kelly, Wada Tetsuyuki, Sekiguchi Fumiko, Ichida Seiji, Hollenberg Morley D, MacNaughton Wallace K, Nishikawa Hiroyuki, Kawabata Atsufumi
Division of Physiology and Pathophysiology, School of Pharmaceutical Sciences, Kinki University, Higashi-Osaka, Japan.
J Pharmacol Exp Ther. 2005 Nov;315(2):576-89. doi: 10.1124/jpet.105.089490. Epub 2005 Aug 24.
We investigated proteinase-activated receptor-2 (PAR(2))-triggered signal transduction pathways causing increased prostaglandin E(2) (PGE(2)) formation in human lung-derived A549 epithelial cells. The PAR(2) agonist, SLIGRL-NH(2) (Ser-Leu-Ile-Gly-Arg-Leu-amide), evoked immediate cytosolic Ca(2+) mobilization and delayed (0.5-3 h) PGE(2) formation. The PAR(2)-triggered PGE(2) formation was attenuated by inhibition of the following signal pathway enzymes: cyclooxygenases 1 and 2 (COX-1 and COX-2, respectively), cytosolic Ca(2+)-dependent phospholipase A(2) (cPLA(2)), the mitogen-activated protein kinases (MAPKs), mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK)-extracellular signal-regulated kinase (ERK) and p38 MAPK, Src family tyrosine kinase, epidermal growth factor (EGF) receptor tyrosine kinase (EGFRK), and protein kinase C (PKC), but not by inhibition of matrix metalloproteinases. SLIGRL-NH(2) caused prompt (5 min) and transient ERK phosphorylation, blocked in part by inhibitors of PKC and tyrosine kinases but not by an EGFRK inhibitor. SLIGRL-NH(2) also evoked a relatively delayed (15 min) and persistent (30 min) phosphorylation of p38 MAPK, blocked by inhibitors of Src and EGFRK but not by inhibitors of COX-1 or COX-2. SLIGRL-NH(2) elicited a Src inhibitor-blocked prompt (5 min) and transient phosphorylation of the EGFRK. SLIGRL-NH(2) up-regulated COX-2 protein and/or mRNA levels that were blocked by inhibition of p38 MAPK, EGFRK, Src, and COX-2 but not MEK-ERK. SLIGRL-NH(2) also caused COX-1-dependent up-regulation of microsomal PGE synthase-1 (mPGES-1). We conclude that PAR(2)-triggered PGE(2) formation in A549 cells involves a coordinated up-regulation of COX-2 and mPGES-1 involving cPLA(2), increased cytosolic Ca(2+), PKC, Src, MEK-ERK, p38 MAPK, Src-mediated EGF receptor trans-activation, and also metabolic products of both COX-1 and COX-2.
我们研究了蛋白酶激活受体-2(PAR(2))触发的信号转导途径,该途径可导致人肺源A549上皮细胞中前列腺素E2(PGE(2))生成增加。PAR(2)激动剂SLIGRL-NH(2)(丝氨酸-亮氨酸-异亮氨酸-甘氨酸-精氨酸-亮氨酸-酰胺)可引起胞质Ca(2+)迅速动员以及延迟(0.5 - 3小时)的PGE(2)生成。通过抑制以下信号通路酶可减弱PAR(2)触发的PGE(2)生成:环氧化酶1和2(分别为COX-1和COX-2)、胞质Ca(2+)依赖性磷脂酶A2(cPLA(2))、丝裂原活化蛋白激酶(MAPKs)、丝裂原活化蛋白激酶/细胞外信号调节激酶激酶(MEK)-细胞外信号调节激酶(ERK)和p38 MAPK、Src家族酪氨酸激酶、表皮生长因子(EGF)受体酪氨酸激酶(EGFRK)以及蛋白激酶C(PKC),但抑制基质金属蛋白酶则无此作用。SLIGRL-NH(2)可引起迅速(5分钟)且短暂的ERK磷酸化,部分被PKC和酪氨酸激酶抑制剂阻断,但未被EGFRK抑制剂阻断。SLIGRL-NH(2)还可引起相对延迟(15分钟)且持续(30分钟)的p38 MAPK磷酸化,被Src和EGFRK抑制剂阻断,但未被COX-1或COX-2抑制剂阻断。SLIGRL-NH(2)可引起Src抑制剂阻断的迅速(5分钟)且短暂的EGFRK磷酸化。SLIGRL-NH(2)上调COX-2蛋白和/或mRNA水平,这被p38 MAPK、EGFRK、Src和COX-2的抑制所阻断,但未被MEK-ERK阻断。SLIGRL-NH(2)还可引起COX-1依赖性微粒体PGE合酶-1(mPGES-1)的上调。我们得出结论,PAR(2)触发的A549细胞中PGE(2)生成涉及COX-2和mPGES-1的协同上调,涉及cPLA(2)、胞质Ca(2+)增加、PKC、Src、MEK-ERK、p38 MAPK、Src介导的EGF受体转活化,以及COX-1和COX-2的代谢产物。